ACC Current Journal Review

Patient outcomes after fibrinolytic therapy for acute myocardial infarction at hospitals with and without coronary revascularization capability
pp. 11-11(1)
Authors: Mehta R.H.; Criger D.A.; Granger C.B.

Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups
pp. 11-11(1)
Authors: Budaj A.; Yusuf S.; Mehta S.R.; the Clopidogrel in Unstable angina to prevent Recurrent Events CURE Trial Investigators

Warfarin, aspirin, or both after myocardial infarction
pp. 11-12(2)
Authors: Hurlen M.; Abdelnoor M.; Smith P.; Erikssen J.; Arnesen H.

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease
pp. 12-12(1)
Authors: Ray W.A.; Stein C.M.; Daugherty J.R.; Hall K.; Arbogast P.G.; Griffin M.R.

Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction: the AMI-SK study
pp. 12-13(2)
Authors: Simoons M.L.; Krzeminska-Pakula M.; Alonso A.

Effect of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomized clinical trial
pp. 13-13(1)
Authors: Dickstein K.; Kjekshus J.; the OPTIMAAL Steering Committee f.t.O.S.G.

Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction. a myocardial ischemia reducation with aggressive cholesterol lowering (MIRACL) substudy
pp. 13-14(2)
Authors: Waters D.D.; Schwartz G.G.; Olsson A.G.; the MIRACL Study Investigator

Effects of end-of-month admission on length of stay and quality of care among inpatients with myocardial infarction
pp. 14-14(1)
Authors: Smith J.P.; Mehta R.H.; Das S.K.

Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial
pp. 14-14(1)
Authors: Deanfield J.E.; Detry J.M.; Sellier P.; the CAPE II Trial Investigators

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
pp. 14-15(2)
Authors: Annane D.; Sebille V.; Charpentier C.

Comparison of low-molecular-weight heparin and warfarin for secondary prevention of venous thromboembolism in patients with cancer. A randomized controlled study
pp. 15-15(1)
Authors: Meyer G.; Marjanovic Z.; Valcke J.

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin k in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial
pp. 15-15(1)
Authors: Crowther M.A.; Douketis J.D.; Schnurr T.

Chronobiological patterns of acute aortic dissection
pp. 16-16(1)
Authors: Mehta R.H.; Manfredini R.; Hassan F.; the International Registry of Acute Aortic Dissection IRAD Investigators

Long-term prognosis of patients with type A aortic intramural hematoma
pp. 16-16(1)
Authors: Kaji S.; Akasaka T.; Horibata Y.

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism
pp. 16-17(2)
Authors: Konstantinides S.; Geibel A.; Heusel G.

Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism
pp. 17-17(1)
Authors: Konstantinides S.; Geibel A.; Olschewski M.

Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism
pp. 17-18(2)
Authors: Dunn K.L.; Wolf J.P.; Dorfman D.M.; Fitzpatrick P.; Baker J.L.; Goldhaber S.Z.

Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?
pp. 18-18(1)
Authors: Majumdar S.R.; Chang W.C.; Armstrong P.W.

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs. conventional fibrinolytic therapy for acute myocardial infarction. GUSTO V randomized trial
pp. 18-18(1)
Authors: Lincoff A.M.; Califf R.M.; Van de Werf F.

Mesenteric ischemia: identification and treatment
pp. 19-21(3)
Authors: Barkhordarian S.; Gusberg R.J.

Predicting incidence of some critical events by sun signs-the Pisces study
pp. 22-24(3)
Authors: Gurm H.S.; Lauer M.S.

Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: A systematic review
pp. 28-28(1)
Authors: Teo K.K.; Yusuf S.; Pfeffer M.; the ACE Inhibitors Collaborative Group

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis from the women's health initiative observational study
pp. 28-28(1)
Authors: Pradhan A.D.; Manson J.E.; Rossouw J.E.

Statin-associated myopathy with normal creatine kinase levels
pp. 28-29(2)
Authors: Phillips P.S.; Haas R.H.; Bannykh S.

Walking compared with vigorous exercise for the prevention of cardiovascular events in women
pp. 29-29(1)
Authors: Manson J.E.; Greenland P.; LaCroix A.Z.

Exercise type and intensity in relation to coronary heart disease in men
pp. 29-30(2)
Authors: Tanasescu M.; Leitzmann M.F.; Rimm E.B.; Willett W.C.; Stampfer M.J.; Hu F.B.

Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes. South thames trial of antibiotics in myocardial infarction and unstable angina pectoris (STAMINA)
pp. 30-30(1)
Authors: Stone A.F.M.; Mendall M.A.; Kaski J.C.

Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein (a), homocysteine, and pulmonary nitric oxide. A randomized, controlled, crossover trial
pp. 30-31(2)
Authors: Jenkins D.J.A.; Kendall C.W.C.; Marchie A.

Alpha-tocopherol supplementation in healthy-individuals reduces low-density lipoprotein oxidation but not atherosclerosis. The vitamin E atherosclerosis prevention study (VEAPS)
pp. 31-31(1)
Authors: Hodis H.N.; Mack W.J.; LaBree L.; the VEAPS Research Group

Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. The framingham heart study
pp. 31-32(2)
Authors: Vasan R.S.; Benjamin E.F.; Larson M.G.

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) study
pp. 32-32(1)
Authors: Kjeldsen S.E.; Dahlor B.; Devereux R.B.; the LIFE Study Group

The prevention of dementia with antihypertensive treatment. New evidence from the systolic hypertension in europe (Syst-Eur) study
pp. 32-33(2)
Authors: Forette F.; Seux M.L.; Staessen J.A.; the Syst-Eur Investigators

Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory
pp. 37-37(1)
Authors: Nishimura R.A.; Grantham J.A.; Connolly H.M.; Schaff H.V.; Higano S.T.; Holmes D.R.

Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the framingham heart study
pp. 37-37(1)
Authors: Freed L.A.; Benjamin E.J.; Levy D.

Natural history of asymptomatic mitral valve prolapse in the community
pp. 37-38(2)
Authors: Avierinos J.F.; Gersh B.J.; Melton L.J.

Electromechanical mapping for determination of myocardial contractility and viability: a comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography
pp. 38-38(1)
Authors: Keck A.; Hertting K.; Schwartz Y.

Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography
pp. 38-39(2)
Authors: Yuda S.; Khoury V.; Marwick T.H.

Coronary recanalization in anterior myocardial infarction: the open perforator hypothesis
pp. 39-39(1)
Authors: Voci P.; Mariano E.; Pizzuto F.; Puddu P.E.; Romeo F.

The effect of estrogen compared to estrogen plus progesterone on the exercise electrocardiogram
pp. 39-39(1)
Authors: Bokhari S.; Bergmann S.R.

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans
pp. 44-44(1)
Authors: Strauer B.E.; Brehm M.; Zeus T.

Plasma brain natriuretic peptide concentration: impact of age and gender
pp. 44-44(1)
Authors: Redfield M.M.; Rodeheffer R.J.; Jacobsen S.J.; Mahoney D.W.; Bailey K.R.; Burnett J.C.

The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure
pp. 44-45(2)
Authors: Mahon N.G.; Blackstone E.H.; Francis G.S.; Starling R.C.; Young J.B.; Lauer M.S.

Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care
pp. 45-45(1)
Authors: Capomolla S.; Febo O.; Ceresa M.

Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy
pp. 45-46(2)
Authors: Rossi A.; Cicoira M.; Zanolla L.

Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy
pp. 46-46(1)
Authors: Fernandez-Sola J.; Nicolas J.M.; Oriola J.

Valsartan benefits left ventricular structure and function in heart failure: val-heft echocardiographic study
pp. 46-47(2)
Authors: Wong M.; Staswzewsky L.; Latini R.; the Val-HeFT Heart Failure Trial Investigators

Increased tissue factor expression predicts development of cardiac allograft vasculopathy
pp. 47-47(1)
Authors: Yen M.H.; Pilkington G.; Starling R.C.

Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation
pp. 47-47(1)
Authors: Bengel F.M.; Ueberfuhr P.; Hesse T.

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia
pp. 47-48(2)
Authors: Anderson L.J.; Wonke B.; Prescott E.; Holden S.; Walker J.M.; Pennell D.J.

Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction
pp. 57-57(1)
Authors: Herrmann J.; Lerman A.; Baumgart D.

Angiographic findings of the multicenter randomized study with the sirolimus-eluting bx velocity balloon-expandable stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size
pp. 57-57(1)
Authors: Regar E.; Serruys P.W.; Bode C.; the RAVEL Study Group

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation
pp. 57-58(2)
Authors: Degertekin M.; Serruys P.W.; Foley D.P.

Randomized trial of 90sr/90y beta-radiation vs. placebo control for treatment of in-stent restenosis
pp. 58-58(1)
Authors: Popma J.J.; Suntharalingam M.; Lansky A.J.; the Stents And Radiation Therapy START Investigators

Effect of homocysteine-lowering therapy with folic acid, vitamin B₁₂, and vitamin B₆ on clinical outcome after percutaneous coronary intervention. the swiss heart study: a randomized controlled trial
pp. 58-59(2)
Authors: Schnyder G.; Roffi M.; Flammer Y.; Pin R.; Hess O.M.

Primary angioplasty vs. prehospital fibrinolysis in acute myocardial infarction: a randomised study
pp. 59-59(1)
Authors: Bonnefoy E.; Lapostolle F.; Leizorovicz A.; the Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction CAPTIM Study Group

Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial
pp. 59-60(2)
Authors: Holmes D.R.; Savage M.; LaBlanche J.M.

The impact of plasma levels of c-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting. the global evaluation of new events and restenosis after stent implantation study
pp. 60-60(1)
Authors: Zairis M.N.; Ambrose J.A.; Manousakis S.J.; the GENERATION Study Group

Interventional vs. conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the british heart foundation RITA 3 randomized trial
pp. 60-61(2)
Authors: Fox K.A.A.; Poole-Wilson P.A.; Henderson R.A.

Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction
pp. 61-61(1)
Authors: Mahoney E.M.; Jurkovitz C.T.; Chu H.; the TACTICS-TIMI 18 Investigators

Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the open artery trial (TOAT study)
pp. 61-62(2)
Authors: Yousef Z.R.; Redwood S.R.; Bucknall C.A.; Sulke A.N.; Marber M.S.

Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound
pp. 62-62(1)
Authors: Maehara A.; Mintz G.S.; Bui A.B.

Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease
pp. 62-63(2)
Authors: Duda S.H.; Pusich B.; Richter G.

Feasibility and efficacy of balloon-based neuroprotection during carotid artery stenting in a single-center setting
pp. 63-63(1)
Authors: Schluter M.; Tubler T.; Mathey D.G.; Schofer J.

Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy
pp. 63-64(2)
Authors: Shamim W.; Yousufuddin M.; Wang D.

Public use of automated external defibrillators
pp. 71-71(1)
Authors: Caffrey S.L.; Willoughby P.J.; Pepe P.E.; Becker L.B.

Impact of community-wide police car deployment of automated external defibrillators on survival from out-of-hospital cardiac arrest
pp. 71-71(1)
Authors: Myerburg R.J.; Fenster J.; Velez M.

Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation
pp. 71-72(2)
Authors: Cappuci A.; Aschieri D.; Piepoli M.F.

Torsade de pointes associated with very-high-dose methadone
pp. 72-72(1)
Authors: Krantz M.J.; Lewkowiez L.; Hays H.; Woodroffe M.A.; Robertson A.D.; Mehler P.S.

Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation. Feasibility and mechanistic insights
pp. 72-72(1)
Authors: Oral H.; Knight B.P.; Ozaydin M.; Chugh A.

Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation. Impact of different catheter technologies
pp. 72-73(2)
Authors: Marrouche N.F.; Dresing T.; Cole C.

Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy
pp. 73-73(1)
Authors: Saksena S.; Prakash A.; Ziegler P.

Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion
pp. 73-73(1)
Authors: Gallagher M.M.; Hennessy B.J.; Edvardsson N.

Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome
pp. 73-74(2)
Authors: Colivicchi F.; Ammirati F.; Biffi A.

Management of vasovagal syncope, controlling or aborting faints by leg crossing and muscle tensing
pp. 74-74(1)
Authors: Krediet C.T.P.; van Dijk N.; Linzer M.; van Lieshout J.J.; Wieling W.

Incidence and prognosis of syncope
pp. 74-74(1)
Authors: Soteriades E.S.; Evans J.C.; Larson M.G.

Pulmonary vein ablation for atrial fibrillation: when should this be the treatment of choice?
pp. 75-78(4)
Authors: Pappone C.; Rosanio S.

Coronary artery bypass surgery vs. percutaneous coronary intervention with stent implantation in patients with multivessel coronary disease (the stent or surgery trial): a randomized controlled trial
pp. 81-81(1)
Author: The SoS Investigators

Reduced mortality and strokes with off-pump coronary artery bypass grafting surgery in octogenarians
pp. 81-81(1)
Authors: Demaria R.G.; Carrier M.; Fortier S.

Mortality in medicare beneficiaries following coronary artery bypass graft surgery in states with and without certificate of need regulation
pp. 81-82(2)
Authors: Vaughan-Sarrazin M.S.; Hanna E.L.; Gormley C.J.; Rosenthal G.E.

Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome
pp. 82-82(1)
Authors: Jones H.U.; Muhlestein J.B.; Jones K.W.

High failure rate after valve-sparing aortic root replacement using the ''remodeling technique'' in acute type A aortic dissection
pp. 82-83(2)
Authors: Leyh R.G.; Fischer S.; Kallenbach K.; Kofidis T.; Pethig K.; Harringer W.; Haverich A.

Does profound hypothermic circulatory arrest improve survival in patients with acute type A aortic dissection?
pp. 83-83(1)
Authors: Lai D.T.; Robbins R.C.; Mitchell R.S.

Hemodynamic performance at rest and during exercise after aortic valve replacement: comparison of pulmonary autografts vs. aortic homografts
pp. 83-84(2)
Authors: Laforest I.; Dumesnil J.G.; Briand M.; Cartier P.C.; Pibarot P.

Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling
pp. 84-84(1)
Authors: Connolly H.M.; Schaff H.V.; Mullany C.J.; Abel M.D.; Pellikka P.A.

Endovascular stent grafting vs. open surgical operation in patients with infrarenal aortic aneurysms: a propensity score-adjusted analysis
pp. 84-84(1)
Authors: Teufelsbauer H.; Prusa A.M.; Wolff K.

A man with fatigue 15 years after bypass surgery
pp. 85-85(1)

The answer is:
pp. 86-86(1)

Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: a single-center experience
pp. 90-90(1)
Authors: Bruch L.; Parsi A.; Grad M.O.; Rux S.; Burmeister T.; Krebs H.; Kleber F.X.

Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism
pp. 90-90(1)
Authors: Martin F.; Sanchez P.L.; Doherty E.

Usefulness of laser-assisted valvotomy with balloon valvoplasty for pulmonary valve atresia with intact ventricular septum
pp. 90-91(2)
Authors: Cheung Y.; Leung M.P.; Chau A.K.T.

Sequential follow-up results of catheter invention for coronary artery lesions after Kawasaki disease: quantitative coronary artery. Angiography and intravascular ultrasound imaging
pp. 91-91(1)
Authors: Ishii M.; Ueno T.; Ikeda H.

Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease
pp. 91-92(2)
Authors: Bolger A.P.; Sharma R.; Li W.

Normal coronary flow reserve after arterial switch operation for transposition of the great arteries: an intracoronary doppler guidewire study
pp. 92-92(1)
Authors: Oskarsson G.; Pesonen E.; Munkhammar P.; Sandstrom S.; Jogi P.

Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries
pp. 92-93(2)
Authors: Beauchesne L.M.; Warnes C.A.; Connolly H.M.; Ammash N.M.; Tajik A.J.; Danielson G.K.

Progressive aortic root dilatation in adults late after repair of tetralogy of Fallot
pp. 93-93(1)
Authors: Niwa K.; Siu S.C.; Webb G.D.; Gatzoulis M.A.

Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of Fallot
pp. 93-94(2)
Authors: Vliegen H.W.; van Straten A.; de Roos A.

Ventricular afterload and ventricular work in Fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with Blalock-Taussig shunts
pp. 94-94(1)
Authors: Senzaki H.; Masutani S.; Kobayashi J.

Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients
pp. 94-95(2)
Authors: Deal B.J.; Mavroudis C.; Backer C.L.

Female sex as a risk factor for in-hospital mortality among children undergoing cardiac surgery
pp. 95-95(1)
Authors: Chang R.K.R.; Chen A.Y.; Klitzner T.S.

Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients
pp. 95-96(2)
Authors: Tweddell J.S.; Hoffman G.M.; Mussatto K.A.

The adult with successful childhood repair of ASD/Coarctation/or VSD: what should i watch for?
pp. 97-100(4)
Authors: Grogan M.; Warnes C.A.